Trial no.:
|
PACTR202007753364675 |
Date of Approval:
|
08/07/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effects of Speculum Lubrication on Cervical Smears for Cervical Cancer Screening in Nnewi: A Randomized Controlled Study |
Official scientific title |
Effects of Speculum Lubrication on Cervical Smears for Cervical Cancer Screening in Nnewi: A Randomized Controlled Study |
Brief summary describing the background
and objectives of the trial
|
Background:
Carcinoma of the cervix is the most prevalent gynaecological malignancy in this environment, associated with significant morbidity and mortality. Papanicolaou test is a well-recognised and efficient screening modality but the uptake of Pap smear in our environment remains poor. Fear of pain from speculum insertion during vaginal examination has been noted as a factor that may reduce the compliance of women to cervical cancer screening and repeat testing. Speculum lubrication may help to reduce these pain and discomfort, but there are fears of its interference with cytological results.
Aim and Objectives:
To determine and compare adequacy of cervical cytology smears and mean pain scores of women undergoing cervical screening with or without speculum lubrication.
Research Methodology:
This proposed work will be a randomized controlled study among women having cervical cancer screening at the gynaecological clinic of Nnamdi Azikiwe University Teaching Hospital, Nnewi. Sixty-six patients would be randomly assigned to the ‘Gel group’ and another 66 patients to the ‘No Gel’ group. Samples will be collected from each participant for Pap smear with lubricated vaginal speculum for the ‘Gel group’ and non-lubricated vaginal speculum for the ‘No Gel group’. Pain scores will be assessed with the numeric rating scale for pain. The primary outcome measures will be the mean numeric rating scale pain scores and proportion of women with inadequate cervical cytology smears. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Cancer,Obstetrics and Gynecology,Pregnancy and Childbirth,Urological and Genital Diseases |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Early detection /Screening |
Anticipated trial start date |
11/07/2020 |
Actual trial start date |
21/08/2020 |
Anticipated date of last follow up |
31/12/2020 |
Actual Last follow-up date |
31/12/2020 |
Anticipated target sample size (number of participants) |
132 |
Actual target sample size (number of participants) |
132 |
Recruitment status |
Completed |
Publication URL |
|
|